{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:12:06Z","timestamp":1793661126199,"version":"4.5.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:00:00Z","timestamp":1485302400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12519-017-0011-z","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:01:25Z","timestamp":1485302485000},"page":"465-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ataxia telangiectasia in Turkey: multisystem involvement of 91 patients"],"prefix":"10.1007","volume":"13","author":[{"given":"Hacer","family":"Akturk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sutcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayper","family":"Somer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanem","family":"Piskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolya","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Altinoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Tatli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuran","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,25]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2015.05.022","volume":"355","author":"HA Teive","year":"2015","unstructured":"Teive HA, Moro A, Moscovich M, Arruda WO, Munhoz RP, Raskin S, et al. Ataxia-telangiectasia-a historical review and a proposal for a new designation: ATM syndrome. J Neurol Sci 2015;355:3\u20136.","journal-title":"J Neurol Sci"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/336577a0","volume":"336","author":"RA Gatti","year":"1988","unstructured":"Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 1988;336:577\u2013580.","journal-title":"Nature"},{"key":"11_CR3","first-page":"159","volume":"7","author":"MW Chaudhary","year":"2014","unstructured":"Chaudhary MW, Al-Baradie RS. Ataxia-telangiectasia: future prospects. Appl Clin Genet 2014;7:159\u2013167.","journal-title":"Appl Clin Genet"},{"key":"11_CR4","unstructured":"European Society for Immunodeficiency, 2005. http:\/\/esid.org\/Resources\/Ataxia-Telangiectasia (accessed December 29, 2015)."},{"key":"11_CR5","first-page":"3464","volume-title":"Nelson textbook of pediatrics","author":"SF Lo","year":"2015","unstructured":"Lo SF. Reference intervals for laboratory tests and procedures. In: Kiegman RM, Stanton BF, Geme JW, Schor NF, eds. Nelson textbook of pediatrics, 20th ed. Canada: Elsevier, 2015:3464\u20133473.","edition":"20"},{"key":"11_CR6","first-page":"541","volume":"1","author":"L Syllabe","year":"1926","unstructured":"Syllabe L, Henner K. Contribution a l\u2019independance de l\u2019athetose double idiopathique et congenitale: atteinte familiale, syndrome dystrophique, signe du reseau vasculaire conjonctival, integrite psychique. Rev Neurol (Paris) 1926;1:541\u2013562.","journal-title":"Rev Neurol (Paris)"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.21.4.526","volume":"21","author":"E Boder","year":"1958","unstructured":"Boder E, Sedgwick RP. Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 1958;21:526\u2013554.","journal-title":"Pediatrics"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/S0140-6736(72)92717-1","volume":"2","author":"TA Waldmann","year":"1972","unstructured":"Waldmann TA, McIntire KR. Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia. Lancet 1972;2:1112\u20131115.","journal-title":"Lancet"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/mds.870080222","volume":"8","author":"JH Friedman","year":"1993","unstructured":"Friedman JH, Weitberg A. Ataxia without telangiectasia. Mov Disord 1993;8:223\u2013226.","journal-title":"Mov Disord"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0022-510X(84)90019-4","volume":"66","author":"E Byrne","year":"1984","unstructured":"Byrne E, Hallpike JF, Manson JI, Sutherland GR, Thong YH. Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability. J Neurol Sci 1984;66:307\u2013317.","journal-title":"J Neurol Sci"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ajmg.1320450624","volume":"45","author":"PJ Willems","year":"1993","unstructured":"Willems PJ, Van Roy BC, Kleijer WJ, Van der Kraan M, Martin JJ. Atypical clinical presentation of ataxia telangiectasia. Am J Med Genet 1993;45:777\u2013782.","journal-title":"Am J Med Genet"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/jmg.24.11.669","volume":"24","author":"AM Taylor","year":"1987","unstructured":"Taylor AM, Flude E, Laher B, Stacey M, McKay E, Watt J, et al. Variant forms of ataxia telangiectasia. J Med Genet 1987;24:669\u2013677.","journal-title":"J Med Genet"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1749-6632.2011.06242.x","volume":"1238","author":"O Sanal","year":"2011","unstructured":"Sanal O, Tezcan I. Thirty years of primary immunodeficiencies in Turkey. Ann N Y Acad Sci 2011;1238:15\u201323.","journal-title":"Ann N Y Acad Sci"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2007.03.002","volume":"37","author":"M Moin","year":"2007","unstructured":"Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari SR, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol 2007;37:21\u201328.","journal-title":"Pediatr Neurol"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0738-081X(95)90007-Q","volume":"13","author":"RA Gatti","year":"1995","unstructured":"Gatti RA. Ataxia-telangiectasia. Dermatol Clin 1995;13:1\u20136.","journal-title":"Dermatol Clin"},{"key":"11_CR16","first-page":"169","volume":"82","author":"CG Woods","year":"1992","unstructured":"Woods CG, Taylor AM. Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals. Q J Med 1992;82:169\u2013179.","journal-title":"Q J Med"},{"key":"11_CR17","first-page":"110","volume-title":"Little club clinics in developmental medicine","author":"E Boder","year":"1963","unstructured":"Boder E, Sedgwick RP. Ataxia-telangiectasia: a review of 101 cases. In: Walsh G, eds. Little club clinics in developmental medicine. London: Heinemann Books, 1963:110\u2013118."},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pediatrneurol.2014.04.027","volume":"51","author":"F Hoche","year":"2014","unstructured":"Hoche F, Frankenberg E, Rambow J, Theis M, Harding JA, Qirshi M, et al. Cognitive phenotype in ataxia-telangiectasia. Pediatr Neurol 2014;51:297\u2013310.","journal-title":"Pediatr Neurol"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1365-2249.2008.03684.x","volume":"153","author":"ER Staples","year":"2008","unstructured":"Staples ER, McDermott EM, Reiman A, Byrd PJ, Ritchie S, Taylor AM, et al. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol 2008;153:214\u2013220.","journal-title":"Clin Exp Immunol"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","volume":"144","author":"A Nowak-Wegrzyn","year":"2004","unstructured":"Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxiatelangiectasia. J Pediatr 2004;144:505\u2013511.","journal-title":"J Pediatr"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/cei.12262","volume":"176","author":"C Chopra","year":"2014","unstructured":"Chopra C, Davies G, Taylor M, Anderson M, Bainbridge S, Tighe P, et al. Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients. Clin Exp Immunol 2014;176:275\u2013282.","journal-title":"Clin Exp Immunol"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ppul.22817","volume":"49","author":"SA Schroeder","year":"2014","unstructured":"Schroeder SA, Zielen S. Infections of the respiratory system in patients with ataxia-telangiectasia. Pediatr Pulmonol 2014;49:389\u2013399.","journal-title":"Pediatr Pulmonol"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/039463201402700312","volume":"27","author":"E Azarsiz","year":"2014","unstructured":"Azarsiz E, Karaca NE, Gunaydin NC, Gulez N, Ozturk C, Aksu G, et al. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia? Int J Immunopathol Pharmacol 2014;27:421\u2013427.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/adc.2008.149351","volume":"94","author":"JG Noordzij","year":"2009","unstructured":"Noordzij JG, Wulffraat NM, Haraldsson A, Meyts I, van\u2019t Veer LJ, Hogervorst FB, et al. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome. Arch Dis Child 2009;94:448\u2013449.","journal-title":"Arch Dis Child"},{"key":"11_CR25","first-page":"89","volume":"77","author":"D Morrell","year":"1986","unstructured":"Morrell D, Cromartie BA, Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 1986;77:89\u201392.","journal-title":"J Natl Cancer Inst"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","volume":"33","author":"F Suarez","year":"2015","unstructured":"Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois d\u2019Enghien C, Brousse N, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol 2015;33:202\u2013208.","journal-title":"J Clin Oncol"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1056\/NEJM199112263252602","volume":"325","author":"M Swift","year":"1991","unstructured":"Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. Engl J Med 1991;325:1831\u20131836.","journal-title":"Engl J Med"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0190-9622(84)80089-4","volume":"10","author":"LE Cohen","year":"1984","unstructured":"Cohen LE, Tanner DJ, Schaefer HG, Levis WR. Common and uncommon cutaneous findings in patients with ataxiatelangiectasia. J Am Acad Dermatol 1984;10:431\u2013438.","journal-title":"J Am Acad Dermatol"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0022-3476(05)83043-4","volume":"119","author":"AS Paller","year":"1991","unstructured":"Paller AS, Massey RB, Curtis MA, Pelachyk JM, Dombrowski HC, Leickly FE, et al. Cutaneous granulomatous lesions in patients with ataxia-telangiectasia. J Pediatr 1991;119:917\u2013922.","journal-title":"J Pediatr"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jaad.2012.12.950","volume":"68","author":"S Greenberger","year":"2013","unstructured":"Greenberger S, Berkun Y, Ben-Zeev B, Levi YB, Barziliai A, Nissenkorn A. Dermatologic manifestations of ataxiatelangiectasia syndrome. J Am Acad Dermatol 2013;68:932\u2013936.","journal-title":"J Am Acad Dermatol"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1365-2133.2005.06619.x","volume":"153","author":"A Mitra","year":"2005","unstructured":"Mitra A, Pollock B, Gooi J, Darling JC, Boon A, Newton-Bishop JA. Cutaneous granulomas associated with primary immunodeficiency disorders. Br J Dermatol 2005;153:194\u2013199.","journal-title":"Br J Dermatol"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1182\/blood.V95.11.3460","volume":"95","author":"FD Goldman","year":"2000","unstructured":"Goldman FD, Gilman AL, Hollenback C, Kato RM, Premack BA, Rawlings DJ. Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties. Blood 2000;95:3460\u20133466.","journal-title":"Blood"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.jaci.2013.02.026","volume":"131","author":"J Loosdregt van","year":"2013","unstructured":"van Loosdregt J, Spreafico R, Rossetti M, Prakken BJ, Lotz M, Albani S. Hydroxychloroquine preferentially induces apoptosis of CD45RO+ effector T cells by inhibiting autophagy: a possible mechanism for therapeutic modulation of T cells. J Allergy Clin Immunol 2013;131:1443\u20131446.","journal-title":"J Allergy Clin Immunol"},{"key":"11_CR34","first-page":"803","volume":"20","author":"K Sperber","year":"1993","unstructured":"Sperber K, Quraishi H, Kalb TH, Panja A, Stecher V, Mayer L. Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells. J Rheumatol 1993;20:803\u2013808.","journal-title":"J Rheumatol"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10875-015-0178-9","volume":"35","author":"A Kiykim","year":"2015","unstructured":"Kiykim A, Ogulur I, Baris S, Salzer E, Karakoc-Aydiner E, Ozen AO, et al. Potentially beneficial effect of hydroxychloroquine in a patient with a novel mutation in protein kinase C\u03b4 deficiency. J Clin Immunol 2015;35:523\u2013526.","journal-title":"J Clin Immunol"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/jpc.12828","volume":"51","author":"LJ Ross","year":"2015","unstructured":"Ross LJ, Capra S, Baguley B, Sinclair K, Munro K, Lewindon P, et al. Nutritional status of patients with ataxia-telangiectasia: a case for early and ongoing nutrition support and intervention. J Paediatr Child Health 2015;51:802\u2013807.","journal-title":"J Paediatr Child Health"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0022-3476(00)70106-5","volume":"136","author":"MA Lefton-Greif","year":"2000","unstructured":"Lefton-Greif MA, Crawford TO, Winkelstein JA, Loughlin GM, Koerner CB, Zahurak M, et al. Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr 2000;136:225\u2013231.","journal-title":"J Pediatr"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1750-1172-6-23","volume":"6","author":"MA Lefton-Greif","year":"2011","unstructured":"Lefton-Greif MA, Crawford TO, McGrath-Morrow S, Carson KA, Lederman HM. Safety and caregiver satisfaction with gastrostomy in patients with Ataxia Telangiectasia. Orphanet J Rare Dis 2011;6:23.","journal-title":"Orphanet J Rare Dis"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/08977194.2014.939805","volume":"32","author":"S Voss","year":"2014","unstructured":"Voss S, Pietzner J, Hoche F, Taylor AM, Last JI, Schubert R, et al. Growth retardation and growth hormone deficiency in patients with Ataxia telangiectasia. Growth Factors 2014;32:123\u2013129.","journal-title":"Growth Factors"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-017-0011-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-017-0011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-017-0011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T18:17:55Z","timestamp":1658513875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-017-0011-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,25]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s12519-017-0011-z","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,25]]}}}